Invesco Ltd. Has $15.26 Million Position in Premier, Inc. (NASDAQ:PINC)

Invesco Ltd. increased its holdings in shares of Premier, Inc. (NASDAQ:PINC) by 23.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 719,597 shares of the company’s stock after buying an additional 137,306 shares during the period. Invesco Ltd. owned about 0.75% of Premier worth $15,255,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in shares of Premier by 61,750.0% in the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock valued at $26,000 after buying an additional 1,235 shares during the last quarter. SRS Capital Advisors Inc. lifted its stake in shares of Premier by 157.8% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock worth $27,000 after acquiring an additional 786 shares during the period. Keystone Financial Group Inc. bought a new stake in Premier in the fourth quarter valued at approximately $37,000. Smartleaf Asset Management LLC increased its position in Premier by 297.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock valued at $40,000 after purchasing an additional 1,427 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new position in Premier during the 3rd quarter worth approximately $39,000. 74.41% of the stock is owned by institutional investors.

Insider Transactions at Premier

In related news, General Counsel David L. Klatsky sold 10,000 shares of the business’s stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $19.53, for a total transaction of $195,300.00. Following the transaction, the general counsel now owns 90,597 shares in the company, valued at $1,769,359.41. The trade was a 9.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Piper Sandler decreased their price target on Premier from $21.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Robert W. Baird decreased their target price on Premier from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Finally, Canaccord Genuity Group dropped their price target on Premier from $21.00 to $19.00 and set a “hold” rating on the stock in a research note on Wednesday, February 5th. Eight investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $20.17.

Premier Price Performance

Shares of NASDAQ:PINC opened at $19.33 on Monday. The company’s fifty day moving average price is $18.69 and its 200-day moving average price is $20.41. The firm has a market capitalization of $1.76 billion, a price-to-earnings ratio of -193.28 and a beta of 0.51. Premier, Inc. has a one year low of $17.23 and a one year high of $23.56.

Premier Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Saturday, March 15th. Stockholders of record on Saturday, March 1st were paid a dividend of $0.21 per share. The ex-dividend date was Friday, February 28th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.35%. Premier’s dividend payout ratio (DPR) is currently -840.00%.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.